US-China Economic and Trade Agreement Phase 1 – Pharmaceutical related IP issues

Event Agenda

10:00-10:10

Welcome remarks
Richard Glanton, Chairman of Board of directors of UCIPF

10:10-10:30

Overview of IP provisions of the recent Economic and Trade Agreement between U.S. and China phase 1

Mark Cohen, Lecturer in Law, Distinguished Senior Fellow, and Director at the University of California at Berkeley
Advisory Board, UCIPF

10:30-11:40

Supplemental Data filing in China and Patent Term Extension

• • Current practice for post filing data in China

Luke Zuo, Senior Partner, NTD Patent & Trademark Agency Limited

• • Current challenges for US Pharmaceutical companies for posting filing data issues in China

R. Craig Tucker, Senior Patent Counsel, Eli Lilly

• • What we expect that China implement the IP provisions of the Economic and Trade Agreement in the future for Post filing data

• • Patent Term Extension

Tom Hoxie, Managing Partner, Hoxie & Associates LLC.

11:40-11:55

Q&A

11:55-12:00

Closing remarks
Demi Wang, Founder, Chief Executive Officer

Thank you to our supporters!